Isolation of cadmium-binding proteins.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMID 5116120)

Published in Experientia on September 15, 1971

Authors

Z A Shaikh, O J Lucis

Articles by these authors

Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci (2001) 1.64

Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology (1999) 1.59

Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler (2000) 1.54

MRI findings in 32 consecutive lipomas using conventional and advanced sequences. J Neuroimaging (1999) 1.48

The status of metformin in Canada. Can Med Assoc J (1983) 1.36

The biosynthesis of metallothionein rat liver and kidney after administration of cadmium. Chem Biol Interact (1976) 1.17

Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport (2000) 1.15

Metabolism of intravenously injected cadmium-binding protein. Biochem Biophys Res Commun (1975) 1.10

Cadmium and zinc binding in mammalian liver and kidneys. Arch Environ Health (1972) 1.08

Cadmium and zinc in pregnancy and lactation. Arch Environ Health (1972) 1.02

MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport (2000) 0.99

Tumorigenesis by cadmium. Oncology (1972) 0.97

Lead nephrotoxicity and associated disorders: biochemical mechanisms. Toxicology (1992) 0.97

Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology (1999) 0.97

The vascular endothelium as a target tissue in acute cadmium toxicity. Life Sci (1986) 0.97

Metallothionein in the extracellular fluids as an index of cadmium toxicity. Environ Health Perspect (1979) 0.93

Elevated urinary excretion of metallothionein due to environmental cadmium exposure. Toxicology (1981) 0.93

Differences in cadmium and mercury uptakes by hepatocytes: role of calcium channels. Toxicol Appl Pharmacol (1991) 0.93

Metallothionein in plasma and urine of cadmium-exposed rats determined by a single-antibody radioimmunoassay. Fundam Appl Toxicol (1983) 0.92

Cytotoxicity of cadmium and characteristics of its transport in cardiomyocytes. Toxicol Appl Pharmacol (1999) 0.92

Sex differences in hepatic and renal cadmium accumulation and metallothionein induction. Role of estradiol. Biochem Pharmacol (1991) 0.91

The mechanisms of hepatic and renal metallothionein biosynthesis in cadmium-exposed rats. Chem Biol Interact (1977) 0.90

Cadmium uptake by primary cultures of rat renal cortical epithelial cells: influence of cell density and other metal ions. Toxicol Appl Pharmacol (1993) 0.89

Biological differences in cadmium and zinc turnover. Arch Environ Health (1972) 0.87

Metallothionein excretion in urine upon cadmium exposure: its relationship with liver and kidney cadmium. Toxicology (1981) 0.87

Distribution of cadmium 109 and zinc 65 in mice of inbred strains. Arch Environ Health (1969) 0.87

Urinary metallothionein and tissue metal levels of rats injected with cadmium, mercury, lead, copper or zinc. Toxicology (1983) 0.86

Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione. Toxicol Appl Pharmacol (1998) 0.86

Turnover of cadmium 109 in rats. Arch Environ Health (1969) 0.86

Metallothionein as a storage protein for cadmium: its toxicological implications. Dev Toxicol Environ Sci (1982) 0.85

Cross-reactivity of metallothioneins from different origins with rabbit anti-rat hepatic metallothione in antibody. Biochem Biophys Res Commun (1978) 0.84

Cadmium and mercury accumulation in rat hepatocytes: interactions with other metal ions. Toxicol Appl Pharmacol (1992) 0.82

Occupational exposure to cadmium: effect on metallothionein and other biological indices of exposure and renal function. Arch Toxicol (1987) 0.82

Uptake and binding of cadmium and mercury to metallothionein in rat hepatocyte primary cultures. Biochem J (1982) 0.81

Urinary metallothionein as a new index of renal dysfunction in "Itai-Itai" disease patients and other Japanese women environmentally exposed to cadmium. Arch Toxicol (1982) 0.81

Renal cortical mitochondrial dysfunction upon cadmium metallothionein administration to Sprague-Dawley rats. J Toxicol Environ Health A (2001) 0.81

An evaluation of tissue metallothionein and genetic resistance to cadmium toxicity in mice. Toxicol Appl Pharmacol (1986) 0.80

Decreased uptake and altered subcellular disposition of testicular cadmium as possible mechanisms of resistance to cadmium-induced testicular necrosis in inbred mice. Toxicology (1984) 0.80

Laboratory observations of assays of serum thyroxine and protein-bound iodine. J Nucl Med (1969) 0.80

Cadmium as a trace element and cadmium binding components in human cells. Experientia (1970) 0.79

Urinary metallothionein as an indicator of cadmium body burden and of cadmium-induced nephrotoxicity. Environ Health Perspect (1984) 0.79

Dose-response relationship between dietary cadmium intake and metallothioneinuria in a population from a cadmium-polluted area of Japan. Toxicology (1991) 0.79

Dose-response relationship between total cadmium intake and metallothioneinuria using logistic regression analysis. Toxicology (1993) 0.79

Dose-response relationship between urinary cadmium and metallothionein in a Japanese population environmentally exposed to cadmium. Toxicology (1991) 0.79

Early-onset Moyamoya syndrome in a patient with Down syndrome: case report and review of the literature. J Child Neurol (2000) 0.79

Dose-response relationship between total cadmium intake and prevalence of renal dysfunction using general linear models. J Appl Toxicol (1995) 0.78

Dose-response relationship in angiotensin bioassay. Cardiovasc Res (1968) 0.78

Application of path analysis to urinary findings of cadmium-induced renal dysfunction. J Environ Sci Health A Tox Hazard Subst Environ Eng (2001) 0.78

Biological indicators of cadmium exposure and toxicity. Experientia Suppl (1986) 0.78

Determination of metallothionein in tissues by radioimmunoassay and by cadmium saturation method. Anal Biochem (1986) 0.78

Developmental and sex differences in cadmium distribution and metallothionein induction and localization. J Appl Toxicol (1988) 0.78

Radioimmunoassay for metallothionein in body fluids and tissues. Methods Enzymol (1991) 0.77

The low molecular weight cadmium-, mercury- and zinc-binding proteins (metallothioneins): biosynthesis, metabolism, and possible role in metal toxicity. Experientia Suppl (1979) 0.77

Dose-effect relationship between ethyl alcohol pretreatment and retention and tissue distribution of mercury vapor in rats. J Pharmacol Exp Ther (1982) 0.77

Resistance to cadmium-induced necrosis in testes of inbred mice: possible role of a metallothionein-like cadmium-binding protein. Toxicol Appl Pharmacol (1985) 0.77

Measurement of cadmium-induced metallothionein in urine by ELISA and prevention of overestimation due to polymerization. J Anal Toxicol (1999) 0.77

Metabolism of orally ingested cadmium in humans. Dev Toxicol Environ Sci (1980) 0.76

Polycystic ovaries associated with congenital adrenal hyperplasia. Can Med Assoc J (1966) 0.76

The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden. Toxicol Appl Pharmacol (1994) 0.76

Differences in the uptake of cadmium and mercury by rat hepatocyte primary cultures. Role of a sulfhydryl carrier. Biochem Pharmacol (1984) 0.76

Present status of clofibrate in Canada. Can Med Assoc J (1981) 0.75

Oral contraceptives and endocrine changes. Bull World Health Organ (1972) 0.75

Observations on immunochemical assays of human chorionic gonadotropin. Can Med Assoc J (1965) 0.75

Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. III. Minimal battery of tests to assess subclinical nephrotoxicity for epidemiological studies based on current knowledge. Ren Fail (1997) 0.75

Utilization of circulating precursors for the synthesis of testosterone by human testis in vivo. Can J Biochem (1967) 0.75

Metabolism of C18 and C19 steroids by testis tissue. Gen Comp Endocrinol (1969) 0.75

Mercury uptake by primary cultures of rat renal cortical epithelial cells. I. Effects of cell density, temperature, and metabolic inhibitors. Toxicol Appl Pharmacol (1995) 0.75

Transformation in cell culture of sex hormones by adenovirus-12-induced tumor cells and normal hamster lung fibroblasts. Cancer Res (1968) 0.75

Subchronic treatment of rats with aurothioglucose; effects on plasma, hepatic, renal and urinary zinc, copper and metallothionein. Toxicology (1987) 0.75

Role of dehydroepiandrosterone and its sulphate in synthesis of testosterone by human testes in vivo and in vitro. J Endocrinol (1970) 0.75

Conversion of dehydroepiandrosterone, pregnenolone, and progesterone by interstitial cell tumor tissue. Cancer Res (1970) 0.75

Biological indicators of cadmium exposure and toxicity. Experientia (1984) 0.75

Induction of metallothionein in rat tissues following subchronic exposure to mercury shown by radioimmunoassay. Biol Trace Elem Res (1987) 0.75

Mercury uptake by LLC-PK1 cells: dependence on temperature and membrane potential. Toxicol Appl Pharmacol (1997) 0.75

Dose-response relationship for renal dysfunction in a population environmentally exposed to cadmium. IARC Sci Publ (1992) 0.75

Comparison of cadmium, mercury and calcium accumulations by isolated hepatocytes of the small skate (Raja erinacea) and rat. Comp Biochem Physiol C (1992) 0.75

Mercury uptake by primary cultures of rat renal cortical epithelial cells. II. Effects of pH, halide ions, and alkali metal ions. Toxicol Appl Pharmacol (1995) 0.75

Metabolism of steroids by transplantable mouse interstitial cell tumor. Cancer Res (1969) 0.75